Fig 1: Hypothesis regarding the miR-142a-3p/Mef2a axis mechanism of regulation of neurogenic skeletal muscle atrophyThe figure was drawn using BioRender website (https://app.biorender.com/gallery).
Fig 2: Knockdown of miR-142a-3p relieves tibialis anterior muscle atrophy after nerve clamp injury(A and B) The results of muscle strength testing and peak muscle strength statistical analysis show that miR-142a-3p alleviates the weakening of muscle strength caused by neurogenic muscle atrophy. (C) Morphological observation of the injured side (R) and healthy side (L) tibialis anterior muscle of each group. (D) H&E staining was used to observe the cross-sections of myotubes. (E, F) Both the wet weight of the injured side/healthy side and the injured side body weight showed that the miR-142a-3p knockdown group retained greater muscle weight. (G) Statistical analysis of bilateral myotube Feret diameters in each group showed that the miR-142a-3p knockdown group retained larger fiber diameters (n = 6 per group; scale bar, 100 μm for D). Control group, PBS group; NC-142a, miR-142a-3p knockdown control; NC-Mef2a, Mef2a knockdown control; MiR-142a-i, miR-142a-3p knockdown; Sh-Mef2a, Mef2a knockdown; L, left; R, Right. Data are presented as the mean ± SEM. ∗p < 0.05; ∗∗p < 0.01.
Fig 3: MiR-142a-3p targets Mef2a in the 3' UTR(A) Schematic diagram of the structural sequence of the Mef2a 3' UTR, Mef2a 3′ UTR mut, miR-142a, and luciferase reporter. (B) The luciferase reporter was transfected into HEK-293T cells with the miR-142a mimic or control, and the luciferase activity was measured 24 h after transfection. (C–E) qRT-PCR and western blot analysis showed that miR-142a-3p inhibits the expression of Mef2a at the mRNA and protein levels (n = 3 per group). (F) TransmiR v2.0 predicted the binding site of Mef2a protein and miR-142a-3p promoter region. (G) Allocation of 12 primers of miR-142 promoter. (H) In Mef2a-knockdown C2C12 cells, miR-142a-3p expression decreased. (I) ChIP analysis of Mef2a at 12 positions of miR-142 promoter in C2C12. NC mimics, overexpression control group; MiR-142a mimics, miR-142a-3p overexpression group; NC inhibitor, knockdown control group; MiR-142a inhibitor, miR-142a-3p knockdown group. Data are presented as the mean ± SEM. ∗p < 0.05; ∗∗p < 0.01.
Fig 4: MiR-142a-3p affects muscle satellite cells and muscle transcriptome expression(A) Blue indicates nuclei, green indicates GFP-tagged protein (the control group image was replaced by a bright field image due to no injection of the virus), and red indicates Pax7+ cells. (B) Counting the number of Pax7+ cells/myotubes in each group showed that the miR-142a-3p knockdown group maintained more activated satellite cells. qRT-PCR was used to detect the expression of genes related to (C) proliferation, (D) muscle atrophy, and (E) muscle differentiation of the bilateral tibialis anterior muscles (n = 6 per group; scale bar, 50 μm). Control group, PBS group; NC-142a, miR-142a-3p knockdown control; NC-Mef2a, Mef2a knockdown control; MiR-142a-i, miR-142a-3p knockdown; Sh-Mef2a, Mef2a knockdown; L, left; R, Right. Data are presented as the mean ± SEM. ∗p < 0.05; ∗∗p < 0.01.
Fig 5: Establishment of the animal model(A) 1 week after injection, the expression level of GFP-tagged protein was observed under a fluorescence microscope. (B) qRT-PCR showed that the miR-142a-3p knockdown rate exceeded 70%. (C and D) Western blot analysis showed that the Mef2a knockdown rate exceeded 70%. (E and F) Immunofluorescence image of the distal sciatic nerve after clamp injury (transverse section). Blue indicates nuclei, green indicates axons, and red indicates Schwann cells. (n = 6 per group; scale bar, 10 μm for F). Control group, PBS group; NC-142a, miR-142a-3p knockdown control; NC-Mef2a, Mef2a knockdown control; MiR-142a-i, miR-142a-3p knockdown; Sh-Mef2a, Mef2a knockdown. Data are presented as the mean ± SEM. ∗p < 0.05; ∗∗p < 0.01.
Supplier Page from OriGene Technologies for Mef2a Mouse shRNA Plasmid (Locus ID 17258)